| Literature DB >> 30625316 |
Tomokazu Murakawa1, Koji Okamoto2, Shigemiki Omiya1, Manabu Taneike1, Osamu Yamaguchi3, Kinya Otsu4.
Abstract
Degradation of mitochondria by selective autophagy, termed mitophagy, contributes to the control of mitochondrial quality. Bcl2-L-13 is a mammalian homolog of Atg32, which is an essential mitophagy receptor in yeast. However, the molecular machinery involved in Bcl2-L-13-mediated mitophagy remains to be elucidated. Here, we show that the ULK1 (unc-51-like kinase) complex is required for Bcl2-L-13 to process mitophagy. Screening of a series of yeast Atg mutants revealed that a different set of ATG genes is used for Bcl2-L-13- and Atg32-mediated mitophagy in yeast. The components of the Atg1 complex essential for starvation-induced autophagy were indispensable in Bcl2-L-13-, but not Atg32-mediated, mitophagy. The ULK1 complex, a counterpart of the Atg1 complex, is necessary for Bcl2-L-13-mediated mitophagy in mammalian cells. We propose a model where, upon mitophagy induction, Bcl2-L-13 recruits the ULK1 complex to process mitophagy and the interaction of LC3B with ULK1, as well as Bcl2-L-13, is important for the mitophagy.Entities:
Keywords: Atg32; Bcl2-L-13; mitochondria; mitophagy
Mesh:
Substances:
Year: 2019 PMID: 30625316 PMCID: PMC6326162 DOI: 10.1016/j.celrep.2018.12.050
Source DB: PubMed Journal: Cell Rep Impact factor: 9.423
Figure 1Bcl2-L-13 Requires Atgs Related to Starvation-Specific Autophagy Pathway
(A) Schematic representation of ATG32 and mouse Bcl2-L-13 domain structure.
(B and C) Yeast cells transfected with HA-Bcl2-L-13 or empty vector were collected 72 hr after induction of mitophagy in glycerol medium (SD-G) and subjected to western blotting for mCherry. Generation of free mCherry is indicated by an arrow-head. Pgk1 was used as a loading control. Yeast strains used are wild-type, atg32Δ, atg1Δ, atg2Δ, atg9Δ, atg14Δ in (B) and wild-type, atg32Δ, atg11Δ/atg32Δ, atg13Δ/atg32Δ, atg17Δ/atg32Δ in (C).
(D) Yeast cells transfected with HA-Bcl2-L-13 or empty vector were collected at indicated time points after the induction of mitophagy by SD-G (left) or nitrogen-starvation medium (SD-N; right).
(E) Yeast cells were collected 48 hr after mitophagy induction in SD-N medium.
See also Figures S1 and S2.
ATG Gene Requirements for Bcl2-L-13-Mediated Mitophagy in Yeast
| Genotype | Mitophagy Restored by Bcl2-L-13 | |
|---|---|---|
| Glycerol Medium (SD-G) | Nitrogen Starvation Medium (SD-N) | |
| − | − | |
| − | − | |
| − | − | |
| − | − | |
| − | − | |
| − | − | |
| − | − | |
| − | − | |
| − | − | |
| − | − | |
| ++ | ++ | |
| − | − | |
| − | − | |
| − | − | |
| − | − | |
| − | − | |
| − | − | |
| ++ | ++ | |
| + | + | |
| − | + | |
| − | + | |
| + | + | |
| + | ++ | |
| − | − | |
| − | − | |
| ++ | ++ | |
| ++ | ++ | |
Mitophagy was assayed by protein degradation assay using mitochondria-targeted mCherry-DHFR-expressing cells grown in glycerol medium for 72 hr or nitrogen starvation medium for 48 hr. Phenotypes are indicated with plus and minus signs as follows: ++, a similar to or higher level than that in atg32Δ; +, a significantly higher level than the corresponding empty vector-transfected strain and lower level than atg32Δ; −, a similar level to the corresponding vector-transfected strain. See also Figure S1.
Figure 2ULK1-LC3B (Atg1-Atg8) Interaction through the LIR (AIM) Motif Is Important for Bcl2-L-13-Mediated Mitophagy
(A) The atg32Δ yeast cells expressing wild-type Atg1 (ATG1 WT/atg32Δ) and AIM mutant of Atg1 (atg1 AIM mutant/atg32Δ) transfected with HA-Bcl2-L-13 or empty vector were collected 72 hr after mitophagy induction in SD-G medium.
(B) Forty-two hours after transfection with HA-Bcl2-L-13, HEK293A cells were treated with pepstatin A and E64d for 4 hr and immunoprecipitated with anti-HA antibody. Co-precipitated endogenous ULK1 and LC3B were detected by immunoblotting.
(C and D) Forty-eight hours after transfection with HA-Bcl2-L-13 and FLAG-tagged wild-type ULK1 or ULK1 mutants, HEK293A cells were immunoprecipitated with anti-HA antibody. Precipitates were immunoblotted with FLAG antibody. Densitometric analysis of the band for FLAG is shown in (D). The value for FLAG-ULK1 wild-type transfected cells in each experiment was set equal to 1 (n = 3). ∗p < 0.05. Results are shown as mean ± SEM.
(E) Proximity ligation assay. HEK293A cells were transfected with FLAG-ULK1 and empty vector or HA-Bcl2-L-13. After 48 hr of transfection, cells were fixed and stained with Duolink and an anti-TOM20. Scale bar : 10 μm.
(F and G) After 48 hr of transfection with HA-Bcl2-L-13 and FLAG tagged wild-type ULK1 or ULK1 mutants, HEK293A cells were stained with Duolink and DAPI. For each experiment, signals from 18 view fields (1674 to 2772 cells) were quantified (n = 3). The number of Duolink positive dots per cell is shown in (G). Scale bar: 100 μm. ∗p < 0.05. Results are shown as mean ± SEM.
See also Figure S3.
Figure 3The ULK1 Complex Is Important for Bcl2-L-13-Mediated Mitophagy
(A and B) HEK293A cells were transfected by indicated siRNA for 72 hr followed by transfection of empty vector or HA-Bcl2-L-13. Forty-two hours after transfection, cells were treated with 100 nM bafilomycin A1 for 6 hr and immunostained with anti-LC3B and anti-ATP synthase antibodies. Images in the box at higher magnification are shown on the right. Representative fluorescent images are shown in (A) and the number of LC3B dots colocalized with ATP synthase dots per cell is shown in (B). At least 20 cells were counted for each group (n = 3). Scale bar: 10 μm. ∗p < 0.05. Results are shown as mean ± SEM.
See also Figure S4.
| REAGENT or RESOURCE | SOURCE | IDENTIFIER |
|---|---|---|
| Rabbit monoclonal anti-HA (clone C29F4) | Cell Signaling Technology | Cat# 3724; RRID: |
| Rabbit polyclonal anti-LC3B | Cell Signaling Technology | Cat# 2775; RRID: |
| Rabbit monoclonal anti-ULK1 (clone D8H5) | Cell Signaling Technology | Cat# 8054; RRID: |
| Rabbit monoclonal anti-FIP200 (clone D10D11) | Cell Signaling Technology | Cat# 12466 |
| Rabbit monoclonal anti-Atg101 (clone E1Z4W) | Cell Signaling Technology | Cat# 13492 |
| Rabbit monoclonal anti-Atg13 (clone D4P1K) | Cell Signaling Technology | Cat# 13273 |
| Mouse monoclonal anti-FLAG (clone M2) | Sigma-Aldrich | Cat# F1804; RRID: |
| Rabbit polyclonal anti-EGFP | Biorbyt | Cat# orb195989 |
| Mouse monoclonal anti-PGK1 (clone 22C5D8) | Abcam | Cat# ab113687; RRID: |
| Mouse monoclonal anti-mCherry (clone 1C51) | Abcam | Cat# ab125096; RRID: |
| Rabbit monoclonal anti-TOMM20 (clone EPR15581-54) | Abcam | Cat# ab209606 |
| Mouse monoclonal anti-ATP synthase subunit b (clone 3D5) | Thermo Fisher | Cat# A-21351; RRID: |
| Sheep anti-mouse IgG | GE Healthcare | Cat# NA931; RRID: |
| Donkey anti-rabbit IgG | GE Healthcare | Cat# NA934; RRID: |
| Penicillin-Streptomycin-Glutamine | GIBCO | Cat# 10378016 |
| geneticin | GIBCO | Cat# 10131-027; CAS: 108321-42-2 |
| nourseothricin | Jena Bioscience | Cat# AB-101S; CAS: 96736-11-7 |
| ScreenFect A | Wako | Cat# 299-73203 |
| RNAi MAX | Invitrogen | Cat# 13778030 |
| Pepstatin A | Sigma | Cat# P5318; CAS: 26305-03-3 |
| E-64d | Sigma | Cat# E8640; CAS: 88321-09-9 |
| Bafilomycin A1 | LC Laboratories | Cat# B-1080; CAS: 88899-55-2 |
| ProLong Gold Antifade Mountant with DAPI | Thermo Fisher Scientific | Cat# P36935 |
| Rabbit Immunoglobulin G | Santa Cruz biochemistry | Cat# sc-2027 |
| Protease Inhibitor Cocktail | Sigma | Cat# P8340 |
| ECL Prime Western Blotting Detection Reagent | GE Healthcare Life Science | Cat# RPN2232 |
| Lumigen ECL Ultra | Lumigen | Cat# TMA-100 |
| Duolink Detaction Reagent kit | Sigma | Cat# DUO92008 |
| Duolink PLA Rabbit PLUS | Sigma | Cat# DUO92002 |
| Duolink PLA Mouse MINUS | Sigma | Cat# DUO92004 |
| Dynabeads Protein A | Invitrogen | Cat# 1001D |
| Human: HEK293A Cell line | Invitrogen | Cat# R70507; RRID: CVCL_6910 |
| See | N/A | |
| siRNA: ULK1 | GE Healthcare Dharmacon | Cat# J-005049-06 |
| siRNA: RB1CC1 | GE Healthcare Dharmacon | Cat# J-021117-08 |
| siRNA: ATG101 | GE Healthcare Dharmacon | Cat# J-017816-09 |
| siRNA: ATG13 | GE Healthcare Dharmacon | Cat# J-020765-12 |
| See | N/A | |
| pRS316-GFP-Atg8 | N/A | |
| HA-Bcl2-L-13-pcDNA3.1 | N/A | |
| p416GPD-Bcl2-L-13(1–407)-TAmito | N/A | |
| p3xFLAG-CMV14-mULK1 | Addgene; Cat# 24301 | |
| p3xFLAG-CMV14-mULK1 K46N | This paper | N/A |
| p3xFLAG-CMV14-mULK1 F357A V360A | This paper | N/A |
| pBS-ATG1-kan | N/A | |
| pBS-ATG1AIM mut-kan | N/A | |
| pFA6a-KanMX6 | N/A | |
| pFA6a-natNT2 | N/A | |
| ImageJ (Version 1.51k) | National Institue of Health, USA | |
| QuPath (Version 0.1.2) | Centre for Cancer Research & Cell Biology, Queen’s University Belfast | |
| BZ-X analyzer | Keyence | N/A |
| GraphPad Prism 7 | GraphPad Software | N/A |